117 Broadway
Unit 4
Nedlands, WA 6009
Australia
61 8 9329 3396
https://argenica.com.au
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Liz Dallimore B.Sc., M.B.A., Ph.D. | CEO, MD & Director | 276,25k | N/A | N/A |
Ms. Emma Waldon | CFO & Company Secretary | N/A | N/A | 1976 |
Prof. Bruno Philip Meloni | Chief Scientific Officer | N/A | N/A | N/A |
Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Argenica Therapeutics Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.